Table 2.
Baseline 30 days before to 7 days after new drug exposure | 8–90 days after new drug exposure | Follow-up 91–270 days after new drug exposure | |
---|---|---|---|
Metformin | 61% | 46% | 72% |
Metformin on PPI | 66% | 48% | 74% |
PPI | 8% | 15% | 26% |
PPI on metformin | 23% | 36% | 63% |